TCT 2025 - In this insightful highlights video from TCT 2025, Dr Mirvat Alasnag (King Fahad Armed Forces Hospital, SA) provides expert commentary on the most impactful late-breaking clinical trials presented at this year's conference.
The commentary distills the most important late-breaking trials in structural cardiology, coronary interventions, and artificial intelligence presented at TCT 2025.
Key trials covered include:
0:40 – SUMMIT MAC (Tendyne TMVR in MAC)
2:25 – PARTNER 3 (7-year TAVR outcomes)
4:10 – CONFIRM 2 AI & angiography-derived physiology
6:05 – SHORTCUT (IVL vs cutting balloon)
7:45 – VICTORY (OPN vs IVL)
Editor: Mirjam Boros, Jordan Rance
Videogrphers: Tom Green, Dan Brent
Support: This is an independent interview produced by Radcliffe Cardiology.
Comments